Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India[1]
- Market Cap ₹ 4,956 Cr.
- Current Price ₹ 1,140
- High / Low ₹ 1,258 / 970
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 4.64 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| 1,780 | 2,522 | 3,300 | |
| 1,758 | 2,498 | 3,236 | |
| Operating Profit | 22 | 24 | 64 |
| OPM % | 1% | 1% | 2% |
| 4 | 4 | 6 | |
| Interest | 20 | 29 | 49 |
| Depreciation | 16 | 20 | 24 |
| Profit before tax | -11 | -20 | -4 |
| Tax % | -42% | -49% | -201% |
| -15 | -29 | -11 | |
| EPS in Rs | -1,550.90 | -77.71 | -28.12 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 62% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|
| Equity Capital | 0 | 4 | 4 | 16 |
| Reserves | -32 | -62 | -73 | 642 |
| Preference Capital | 517 | 619 | 664 | |
| 203 | 355 | 438 | 547 | |
| 662 | 829 | 939 | 301 | |
| Total Liabilities | 833 | 1,125 | 1,308 | 1,506 |
| 189 | 262 | 268 | 262 | |
| CWIP | 2 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| 643 | 863 | 1,040 | 1,244 | |
| Total Assets | 833 | 1,125 | 1,308 | 1,506 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| -69 | -35 | -45 | |
| -31 | -162 | -49 | |
| 89 | 211 | 73 | |
| Net Cash Flow | -11 | 14 | -21 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Debtor Days | 50 | 54 | 57 |
| Inventory Days | 54 | 49 | 41 |
| Days Payable | 22 | 22 | 25 |
| Cash Conversion Cycle | 82 | 81 | 73 |
| Working Capital Days | 84 | 79 | 72 |
| ROCE % | 1% | 5% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 25 Apr
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24 Apr - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015.
- Compliance Certificate As per Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 24 Apr
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 15 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Submission of Certificate under Regulation 74 (5) of SEBI Depository Participant Regulation, 2018 for the quarter ended March 31, 2024.
Concalls
-
Mar 2024Transcript PPT
Leading Healthcare Product Disributor[1] The company is among the top three healthcare distributors in India in terms of revenue. Further, it achieved the fastest scale-up of operations among healthcare product distributors in India between FY19 - FY22.